SRRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SRRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Scholar Rock Holding's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8.74 Mil. Scholar Rock Holding's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $53.08 Mil. Scholar Rock Holding's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $225.22 Mil. Scholar Rock Holding's debt to equity for the quarter that ended in Dec. 2023 was 0.27.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Scholar Rock Holding's Debt-to-Equity or its related term are showing as below:
During the past 8 years, the highest Debt-to-Equity Ratio of Scholar Rock Holding was 0.45. The lowest was -0.06. And the median was 0.13.
The historical data trend for Scholar Rock Holding's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scholar Rock Holding Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Debt-to-Equity | Get a 7-Day Free Trial | 0.05 | 0.22 | 0.45 | 0.27 | 0.27 |
Scholar Rock Holding Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Debt-to-Equity | Get a 7-Day Free Trial | 0.27 | 0.30 | 0.32 | 0.38 | 0.27 |
For the Biotechnology subindustry, Scholar Rock Holding's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Scholar Rock Holding's Debt-to-Equity falls into.
Debt to Equity measures the financial leverage a company has.
Scholar Rock Holding's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (8.742 | + | 53.076) | / | 225.218 | |
= | 0.27 |
Scholar Rock Holding's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (8.742 | + | 53.076) | / | 225.218 | |
= | 0.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scholar Rock Holding (NAS:SRRK) Debt-to-Equity Explanation
In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.
Be Aware
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Thank you for viewing the detailed overview of Scholar Rock Holding's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Mo Qatanani | officer: SVP and Head of Research | 301 BINNEY STREET, 3RD FLOOR, C/O SCHOLAR ROCK HOLDING CORP, CAMBRIDGE MA 02142 |
Caryn Parlavecchio | officer: CHRO | SCHOLAR ROCK HOLDING CORPORATION, 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE MA 02142 |
Junlin Ho | officer: General Counsel | 301 BINNEY STREET, CAMBRIDGE MA 02142 |
Edward H Myles | director | C/O AMAG PHARMACEUTICALS, INC., 1100 WINTER STREET, WALTHAM MA 02451 |
Samsara Biocapital Gp, Llc | 10 percent owner | 251 CHURCHILL AVENUE, PALO ALTO CA 94301 |
Srinivas Akkaraju | director | 565 EVERETT AVENUE, PALO ALTO CA 94301 |
Invus Public Equities, L.p. | 10 percent owner | C/O THE INVUS GROUP, LLC, 750 LEXINGTON AVENUE, 30TH FLOOR, NEW YORK NY 10022 |
Tracey Sacco | officer: Chief Commercial Officer | 301 BINNEY STREET, 3RD FLOOR, C/O SCHOLAR ROCK HOLDING CORP, CAMBRIDGE MA 02142 |
Richard Brudnick | director | BIOVERATIV INC., 225 SECOND AVENUE, WALTHAM MA 02451 |
Jing L. Marantz | officer: Chief Medical Officer | C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH PA 15203 |
Jay T. Backstrom | officer: CEO-Elect | SCHOLAR ROCK HOLDING CORPORATION, 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE MA 02142 |
Amir Nashat | director | 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121 |
Samsara Biocapital, L.p. | 10 percent owner | 628 MIDDLEFIELD ROAD, PALO ALTO CA 94301 |
Artal Group S.a. | 10 percent owner | VALLEY PARK, 44, RUE DE LA VALLEE, LUXEMBOURG N4 L-2661 |
Artal International S.c.a. | 10 percent owner | VALLEY PARK, 44, RUE DE LA VALLEE, LUXEMBOURG N4 L-2661 |
From GuruFocus
By Business Wire • 01-23-2024
By Business Wire • 11-17-2023
By Business Wire • 01-04-2024
By GuruFocus Research • 11-04-2023
By Business Wire Business Wire • 05-09-2023
By Business Wire • 10-11-2023
By Business Wire • 09-19-2023
By Business Wire • 07-13-2023
By Business Wire • 11-02-2023
By Business Wire • 11-07-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.